Splicing factor mutations and cancer
摘要：
Recent advances in high-throughput sequencing technologies have unexpectedly revealed that somatic mutations of splicing factor genes frequently occurred in several types of hematological malignancies, including myelodysplastic syndromes, other myeloid neoplasms, and chronic lymphocytic leukemia. Splicing factor mutations have also been reported in solid cancers such as breast and pancreatic cancers, uveal melanomas, and lung adenocarcinomas. These mutations were heterozygous and mainly affected U2AF1 (U2AF35), SRSF2 (SC35), SF3B1 (SF3B155 or SAP155), and ZRSR2 (URP), which are engaged in the initial steps of RNA splicing, including 3' splice-site recognition, and occur in a large mutually exclusive pattern, suggesting a common impact of these mutations on RNA splicing. In this study, splicing factor mutations in various types of cancers, their functional/biological effects, and their potential as therapeutic targets have been reviewed.
展开
关键词：
Humans Ribonucleoproteins Mutation RNA Splicing Neoplasms High-Throughput Nucleotide Sequencing
DOI：
10.1002/wrna.1222
被引量：
年份：
2014
国家科技图书文献中心
(权威机构)
Wiley
EBSCO
万方医学
Semantic Scholar
查看更多
掌桥科研
dx.doi.org
Europe PMC
NCBI
NCBI
ResearchGate
EBSCO
pubfacts.com
repository.kulib.kyoto-u.ac.jp
学术范
core.ac.uk
hdl.handle.net
onacademic.com
mysciencework.com
repository.kulib.kyoto-u.ac.jp
(全网免费下载)
mendeley.com
core.ac.uk
(全网免费下载)
学术范
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
